These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 690666

  • 41. Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Acta Neurol Scand; 2008 May; 117(5):343-6. PubMed ID: 17995989
    [Abstract] [Full Text] [Related]

  • 42. Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis.
    Hwang CS, Liu GT, Chang MD, Liao IL, Chang HT.
    Neurobiol Dis; 2013 Oct; 58():13-8. PubMed ID: 23639787
    [Abstract] [Full Text] [Related]

  • 43. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
    Zoccolella S, Simone IL, Lamberti P, Samarelli V, Tortelli R, Serlenga L, Logroscino G.
    Neurology; 2008 Jan 15; 70(3):222-5. PubMed ID: 18195267
    [Abstract] [Full Text] [Related]

  • 44. Elevation of cardiac troponin T in patients with amyotrophic lateral sclerosis.
    Mach L, Konecny T, Helanova K, Jaffe AS, Sorenson EJ, Somers VK, Reeder GS.
    Acta Neurol Belg; 2016 Dec 15; 116(4):557-564. PubMed ID: 26801485
    [Abstract] [Full Text] [Related]

  • 45. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I, Janik P, Sokołowska B, Kwiecinski H.
    Eur J Neurol; 2010 Feb 15; 17(2):226-31. PubMed ID: 19796283
    [Abstract] [Full Text] [Related]

  • 46. Increased serum CNTF level in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Eur Cytokine Netw; 2003 Feb 15; 14(3):192-4. PubMed ID: 14656696
    [Abstract] [Full Text] [Related]

  • 47. Serum N-acetylaspartate level in amyotrophic lateral sclerosis.
    Simone IL, Ruggieri M, Tortelli R, Ceci E, D'Errico E, Leo A, Zoccolella S, Mastrapasqua M, Capozzo R, Livrea P, Logroscino G.
    Arch Neurol; 2011 Oct 15; 68(10):1308-12. PubMed ID: 21987545
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA, An J, Hood BL, Conrads TP, Bowser RP.
    J Proteome Res; 2015 Nov 06; 14(11):4486-501. PubMed ID: 26401960
    [Abstract] [Full Text] [Related]

  • 51. Increased levels of MIP-1α in CSF and serum of ALS.
    Yang X, Gao L, Wu X, Zhang Y, Zang D.
    Acta Neurol Scand; 2016 Aug 06; 134(2):94-100. PubMed ID: 26427609
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Cytotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients against acetylcholinesterase.
    Niebrój-Dobosz I, Domitrz I, Mickielewicz A.
    Folia Neuropathol; 1999 Aug 06; 37(2):107-12. PubMed ID: 10464429
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Sera from amyotrophic lateral sclerosis patients reduce high-voltage activated Ca2+ currents in mice dorsal root ganglion neurons.
    Yan HD, Lim W, Lee KW, Kim J.
    Neurosci Lett; 1997 Oct 10; 235(1-2):69-72. PubMed ID: 9389598
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.